The Future of AI in Healthcare Event
In association with UCD research partners, this is a UCD event in partnership with the Analytics Institute, which supports the Data Science and Analytics sector by providing a platform for members to share insights and expertise, collaborate and build industry networks and foster innovation.
Prof Patricia Maguire, Director of UCD Institute for Discovery
The event is co-hosted by its Chief Executive Lorcan Malone and Prof Patricia Maguire, Director of UCD Institute for Discovery. The AI for Healthcare Hub's mission is the democratisation of AI to accelerate projects and deliver meaningful, translational outcomes across UCD, Ireland and globally in both academia and industry.
Event starts: 10am
Zoom link: TBC
Peter Keeling, Chief Executive Officer, Diaceutics Ltd
Peter Keeling is founder and CEO of Diaceutics, the diagnostics commercialisation company helping more patients to get access to precision medicine drugs through better diagnostic testing. Peter has driven Diaceutics from its inception and last year led it to its IPO on the AIM market of the London Stock Exchange.
Peter recognised early on that precision medicine would be an increasingly large part of the drug development paradigm, representing a shift in how the pharmaceutical industry operates. Today, he is a thought leader in precision medicine commercialisation. Diaceutics has worked on every single precision medicine brought to market to date and provides services to 36 of the world’s leading pharmaceutical companies.
Dr Paulina Szklanna, Manager of AI for Healthcare Hub in UCD
Dr Szklanna is a Senior Research Fellow at UCD ConwaySHPHERE research group. Having obtained BSc (Hons) in Biochemistry and Molecular Biology, Paulina joined UCD ConwaySPHERE to complete an interdisciplinary PhD focusing on utilising machine learning and platelet releasate proteomics to discover novel biomarkers for preeclampsia, a devastating pregnancy disorder claiming lives of 50,000 women and 500,000 babies annually.
In her role as a manager of AI for Healthcare Hub, Paulina is collaborating with clinicians and scientists helping them utilize the power of artificial intelligence in order to build risk stratification tools for patients, improve disease diagnosis and determine disease progression for diseases such as multiple sclerosis, COVID-19 and preeclampsia.
Dr Pearse Keane, Consultant Ophthalmologist at Moorfields Eye Hospital, London and Associate Professor at UCL Institute of Ophthalmology.
In 2016, Pearse initiated a formal collaboration between Moorfields Eye Hospital and Google DeepMind, with the aim of developing artificial intelligence (AI) algorithms for the earlier detection and treatment of retinal disease. In August 2018, the first results of this collaboration were published in the journal, Nature Medicine. In May 2020, he jointly led work, again published in Nature Medicine, to develop an early warning system for age-related macular degeneration (AMD), by far the commonest cause of blindness in Ireland and the UK.
10.37am – 10.57am Panel Discussion, Moderated/chaired by Prof Patricia Maguire
An expert panel will discuss (20 mins) the growing role of AI in Healthcare and the implications for the industry. Panellists:
Prof Walter Kolch (Systems Biology Ireland & UCD School of Medicine)
Dr Ashwini Mathur (Head Data Science & Artificial Intelligence Hub Dublin at Novartis)
Oonagh O’Shea (Managing Director at Accenture Applied Intelligence)
Prof Walter Kolch is Director of Systems Biology Ireland (SBI) at University College Dublin (UCD). A leading international proponent of precision medicine, Kolch originally trained as a clinician, subsequently working in the pharmaceutical industry, research institutes, and academia. He is internationally recognised for his cutting-edge research using systems approaches to understand signalling networks, and is ranked 3rd in the world in precision medicine and 8th in personalised medicine.
Dr Ashwini Mathur is Head Data Science & Artificial Intelligence Hub Dublin at Novartis. Novartis Ireland specialises in discovering, developing and successfully marketing innovative healthcare products that strive to prevent and cure diseases, ease the levels of suffering, and enhance the quality of life. He has almost 25 years of experience in the area of clinical research and taught for 4 years as an Adjunct Professor at the Department of Radiology at University of California, San Francisco while doing work on Osteoporosis clinical trials.
Oonagh O’Shea is Managing Director at Accenture Applied Intelligence and specialises in Life Sciences Analytics. Having joined Accenture 9 years ago, Oonagh has extensive experience delivering major analytics programmes across Pharma, Fraud, FS, and Life Sciences.